J&J’s growing rare disease focus brings a potential multi-use treatment to the table

J&J’s growing rare disease focus brings a potential multi-use treatment to the table

Source: 
Pharma Voice
snippet: 

The head of J&J’s autoantibody programs believes nipocalimab is unique among potential rare disease drugs because it can harness a common thread among them.